PHARMACYTE BIOTECH INC's ticker is PMCBD and the CUSIP is 71715X203. A total of 23 filers reported holding PHARMACYTE BIOTECH INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $203,960 | -29.0% | 97,124 | -0.9% | 0.15% | -40.9% |
| Q4 2022 | $287,076 | -78.9% | 97,978 | -82.7% | 0.25% | -85.3% |
| Q3 2022 | $1,362,000 | -42.7% | 567,600 | -46.5% | 1.72% | +6.2% |
| Q2 2022 | $2,378,000 | -19.0% | 1,061,411 | -16.8% | 1.62% | +269.4% |
| Q1 2022 | $2,934,000 | -3.6% | 1,275,468 | +4.7% | 0.44% | -1.1% |
| Q4 2021 | $3,045,000 | -4.9% | 1,217,828 | +20.6% | 0.44% | +2.3% |
| Q3 2021 | $3,202,000 | – | 1,010,146 | – | 0.43% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 1,061,411 | $2,378,000 | 1.62% |
| Ayrton Capital LLC | 153,130 | $343,000 | 0.56% |
| Shay Capital LLC | 982,698 | $2,201,000 | 0.44% |
| EQUITEC PROPRIETARY MARKETS, LLC | 342,994 | $768,000 | 0.22% |
| FNY Investment Advisers, LLC | 15,290 | $34,000 | 0.02% |
| K2 PRINCIPAL FUND, L.P. | 91,095 | $204,000 | 0.02% |
| Schonfeld Strategic Advisors LLC | 26,200 | $59,000 | 0.00% |
| Aspire Private Capital, LLC | 800 | $2,000 | 0.00% |
| OSAIC HOLDINGS, INC. | 1,758 | $3,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 1,734 | $4,000 | 0.00% |